Skip to main content

Abstract

Diabetes mellitus is a complex of syndromes characterized by hyperglycemia and abnormal glucose metabolism. Persistent hyperglycemia leads to a variety of specific microvascular diseases involving the eye, kidney, and the peripheral nerves. In addition, diabetes mellitus is associated with an increased risk of macrovascular disease of the coronary, cerebral, and peripheral vasculature. It is estimated that approximately 6% of the U.S. population (approximately 14 million people) have been diagnosed with diabetes mellitus. An equal number of individuals probably have undiagnosed diabetes mellitus. Diabetes mellitus has a major economic and health impact. In 1992 the direct cost of treating individuals with diabetes mellitus was $85 billion, and the total cost of caring for these individuals was $105 billion. Thus, one in seven health care dollars was spent on treatment of individuals with diabetes mellitus. Individuals with diabetes mellitus are two to three times more likely to be hospitalized and two to four times more likely to have cardiovascular disease than the rest of the population. They also have the highest incidence of blindness, chronic renal failure, and nontraumatic foot amputation. Early diagnosis and appropriate management of diabetes mellitus can prevent or delay the development of complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  • Ahmann AJ, Riddle MC. Current oral agents for type 2 diabetes. Many options, but which to choose when? Postgrad Med 2002;111(5):32–4, 37–40, 43–6.

    Article  PubMed  Google Scholar 

  • American Diabetes Association. Implications of the Diabetes Control and Complications Trial. Diabetes 1993;42:1555–8.

    Google Scholar 

  • American Diabetes Association. Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 2003;26(Suppl 1):S28–S32.

    Google Scholar 

  • American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S33–S50.

    Google Scholar 

  • American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S103–S105.

    Google Scholar 

  • Chan JL, Abrahamson MJ. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin. Mayo Clin Proc 2003;78(4):459–67.

    PubMed  CAS  Google Scholar 

  • DeWitt DE, Hirsch IB. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 2003;289(17):2254–64.

    Article  PubMed  CAS  Google Scholar 

  • Diabetes Control and Complications Trial (DCCT). N Engl J Med 1993;329:683–9.

    Google Scholar 

  • Diamant M, Heine RJ. Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence. Drugs 2003;63(13):1373–405.

    Article  PubMed  CAS  Google Scholar 

  • Edelman SV, Henry RR. Insulin therapy for normalizing glycosylated hemoglobin in type II diabetes: applications, benefits, and risks. Diabetes Rev 1995;3:308–34.

    Google Scholar 

  • Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003;26(Suppl 1):S4–S20.

    Google Scholar 

  • Hirsch IL, Paauw DS, Brunzell J. Inpatient management of adults with diabetes. Diabetes Care 1995;18:870–8.

    PubMed  CAS  Google Scholar 

  • Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 2002;287(3):360–72.

    Article  PubMed  CAS  Google Scholar 

  • Kitabchi A, Ghawji M. Diabetes in the nonpregnant patient. Prim Care Update Ob/Gyn 1994;1(2):86–94.

    Google Scholar 

  • Lebovitz HE. Treating hyperglycemia in type 2 diabetes: new goals and strategies. Cleve Clin J Med 2002;69(10):809–20.

    PubMed  Google Scholar 

  • Petrie J, Small M, Connell J. “Glitazones,” a prospect for non-insulin-dependent diabetes. Lancet 1997;349:70.

    Article  PubMed  CAS  Google Scholar 

  • Santiago JV. Lessons from the Diabetes Control and Complications Trial. Diabetes 1993;42:1549–54.

    PubMed  CAS  Google Scholar 

  • Tsui EYL, Zinman B. Exercise and diabetes: new insights and therapeutic goals. Endocrinologist 1995;5:263–71.

    Google Scholar 

  • Turner RC. The U.K. Prospective Diabetes Study. A review. Diabetes Care 1998;21(Suppl 3):C358.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Mokshagundam, S.P.L., Broadstone, V.L. (2007). Diabetes Mellitus. In: Primary Care in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-32328-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-32328-2_15

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-32327-5

  • Online ISBN: 978-0-387-32328-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics